AstraZeneca PLC

AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH

10 Dec 2023 23:22:28 By NASDAQ US Markets

AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?

10 Dec 2023 09:09:34 By NASDAQ US Markets

Is Now the Right Time to Buy AstraZeneca Stock?

10 Dec 2023 07:46:15 By NASDAQ US Markets

Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy

05 Dec 2023 09:27:21 By NASDAQ Stocks

Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target

04 Dec 2023 08:12:31 By NASDAQ US Markets

AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme

01 Dec 2023 02:39:09 By NASDAQ US Markets

AstraZeneca Launches Evinova Healthtech Business

20 Nov 2023 09:21:15 By NASDAQ US Markets

Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use

17 Nov 2023 09:20:24 By NASDAQ Stocks

AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer

17 Nov 2023 03:04:07 By NASDAQ US Markets

Interesting AZN Put And Call Options For July 2024

16 Nov 2023 11:57:01 By NASDAQ Stocks

AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal

14 Nov 2023 03:55:47 By NASDAQ US Markets

AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View

10 Nov 2023 09:14:44 By NASDAQ Stocks

AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript

09 Nov 2023 18:26:41 By NASDAQ US Markets

AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows

09 Nov 2023 09:57:51 By Forbes - World

Movers & Shakers: AMC shares slide on $350 million stock offer while Walt Disney’s stock jumps on spike in streaming customers

09 Nov 2023 06:19:20 By MarketWatch

: AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines

09 Nov 2023 05:10:57 By MarketWatch

AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial

09 Nov 2023 03:55:26 By NASDAQ US Markets

AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook

09 Nov 2023 03:28:56 By NASDAQ US Markets

US FTC disputes listing for more than 100 patents in FDA Orange Book

07 Nov 2023 13:01:35 By NASDAQ US Markets

AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?

06 Nov 2023 14:44:08 By NASDAQ Stocks